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Abstract
Stem Cell (SC) therapy is one of the most promising approaches for the treatment of Amyotrophic Lateral Sclerosis (ALS).
Here we employed Super Paramagnetic Iron Oxide nanoparticles (SPIOn) and Hoechst 33258 to track human Amniotic Fluid
Cells (hAFCs) after transplantation in the lateral ventricles of wobbler (a murine model of ALS) and healthy mice. By in vitro,
in vivo and ex vivo approaches we found that: 1) the main physical parameters of SPIOn were maintained over time; 2)
hAFCs efficiently internalized SPIOn into the cytoplasm while Hoechst 33258 labeled nuclei; 3) SPIOn internalization did not
alter survival, cell cycle, proliferation, metabolism and phenotype of hAFCs; 4) after transplantation hAFCs rapidly spread to
the whole ventricular system, but did not migrate into the brain parenchyma; 5) hAFCs survived for a long time in the
ventricles of both wobbler and healthy mice; 6) the transplantation of double-labeled hAFCs did not influence mice survival.
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Introduction
The evidence that Amyotrophic Lateral Sclerosis (ALS) also
involves areas apart from the motor system supports the idea of a
multisystemic disease, affecting multiple cell types, which requires
therapeutic treatments able to provide an healthy environment for
degenerating motor neurons and also capable of enhancing
endogenous repair [1]. The potential of Stem Cell (SC) therapy
has been widely demonstrated in different pre-clinical models of
ALS [2] with a significant delay in neurological progression
deriving more from the ability of SCs to produce and release
several neuroprotective factors (bystander effect) than a direct
replacement of degenerating neurons [3,4]. Nevertheless, no
conclusive data on the optimal SC source or delivery route are
currently available either in animal models [5] or in patients [1].
We have recently published a paper describing the therapeutic
efficacy of human cord blood mononuclear cells, labeled with
Hoechst 33258, in two murine models of ALS by direct
administration into brain ventricles [6]. Similarly to intravenous
delivery [7], no migration towards the spinal cord was observed,
thus confirming that the beneficial role of transplanted cells is
independent from their permanence in the site of administration
and their distribution in degenerating host tissues.
The wobbler mouse, a model of spontaneous motor degener-
ation, is characterized by selective motor neuron death affecting
the cervical spinal cord region with no evident features of
degeneration in upper motor neurons of motor cortex [8,9,10].
The wobbler pathology is not exclusively confined to the cervical
spinal cord, but spreads to bulbar motor neurons and neurons
from cerebellum and thalamus [11]. In addition, a significant
reduction of N-acetylaspartate, a putative neuronal marker, in
whole wobbler mice brains has been reported by proton magnetic
resonance spectroscopy [12]. In spite of the encouraging cell
grafting results in murine models of ALS, a careful investigation
into the interaction between transplanted cells and host tissues is
an interesting missing part of preclinical studies. In this context,
several SC labeling strategies have been proposed. Among them,
Super Paramagnetic Iron Oxides nanoparticles (SPIOn) appeared
particularly promising for tracking different types of SCs [13].
In the present study, SPIOn were coupled with the nuclear vital
dye Hoechst 33258 to label a promising source of multipotent SCs,
Amniotic Fluid Cells (hAFCs). hAFCs are an heterogeneous
population, routinely cultured for genetic prenatal diagnostic
testing, containing several undifferentiated and committed pro-
genitor cells whose potential has not been extensively investigated.
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32326Therefore, they constitute an ethically acceptable alternative to
embryonic SCs, maintaining, at the same time, a comparable
multipotentiality and a very low immunogenic response. The
finding that hAFCs are able to express and release numerous
cytokines and neuro-glial factors [14] further encouraged their
application in the field of motor neurodegenerative disorders.
To exclude the possibility that our dual labeling strategy might
lead to significant cell toxicity, the most important parameters of
cell biology were evaluated before hAFC transplantation into the
lateral ventricles of healthy and wobbler mice. Our hypothesis is
that SC administration to the lateral ventricles could favor their
distribution throughout the pathological environment of wobbler
mice by cell flow to different Central Nervous System (CNS) areas.
Our in vivo studies focused exclusively on hAFC tracking over
time in different brain regions before approaching future studies
on possible therapeutic benefits of hAFCs in wobbler mice.
The results emerging from the present work provide interesting
suggestions for future applications of this strategy and SC type to
(pre)clinical therapy.
Materials and Methods
In vitro measurements
Dynamic Laser Light Scattering (DLLS) (Malvern Instruments,
Malvern, UK) was used weekly to measure size, dispersity and z-
potential of carboxydextran coated SPIOn (EndoremH; AMI-25;
11.2 mg Fe/ml, Guerbet, Roissy, France) incubated in distilled
water, saline solution and amniocyte medium (Amniomax II,
Invitrogen, Carlsbad, CA, USA).
SPIOn visualization was performed with an Atomic Force
Microscope (AFM) coupled to NanoScope V system (Veeco
instruments, Plainview, NY USA) operating in tapping mode as
previously described [15].
Electron Spectroscopic Imaging (ESI) was employed to show the
distribution of iron domains in SPIOn using a three-window
method with an Energy Filter Transmission Electron Microscope
(EFTEM, Zeiss LIBRAH 120 Oberlokochen, Germany) for the
overlapping of images with electrons of iron-specific energy loss to
reference images after the two background windows were
subtracted.
Amniotic fluid cell collection and culture
hAFCs were obtained from amniotic fluid samples collected
after written informed consent (approved by the Ethical
Committee of IRCCS-Istituto Auxologico Italiano) from pregnant
women between the 16
th and 21
st week of gestation. Cells were
isolated and grown for one week in Amniomax II (Invitrogen) at
37uC and 5% CO2 in a fully humidified atmosphere. Standard
culture procedures and the Q-banding of chromosomes using
quinacrine (QFQ banding technique) were used for the fetal
karyotype study [16,17]. After cytogenetic analysis, exceeding
cultures from pregnancies with a normal fetal karyotype were
utilized for research purposes, as specified in the informed consent.
In the present work, we used four pools of hAFCs, each one
obtained from 4 different fetal donors (2 with a 46,XX and 2 with
a 46,XY karyotype, respectively; 15
th–17
th gestational week). This
approach was chosen in order to overcome any possible age/
donor/sex-related variation as well as to ensure comparable stocks
were used for the subsequent graft procedures. Cells obtained from
each donor were harvested after trypsinization, centrifuged at
15006g for 10 minutes, pooled together and counted. The cellular
supernatants were collected as well, to avoid the loss of dividing
cells in suspension. Pools were then frozen in aliquots (560,000
cells/aliquot) and stored in liquid nitrogen (ready to use). To check
if enzymatic treatments and subcultures altered hAFC chromo-
some constitution, karyotype was periodically monitored through
routine cytogenetic analysis, as described above.
Tracer internalization and staining procedures
For internalization experiments, hAFCs were maintained for
72 hours in Amniomax II containing SPIOn (35 mg/ml), previ-
ously incubated with Poly-L-Lysine (PLL, Sigma Aldrich, St.
Louis, MO, USA), as described by Bulte and colleagues [18].
After SPIOn incubation, the nuclear dye Hoechst 33258 (2 mg/
ml, Sigma Aldrich) was added to hAFCs for 3 hours [6].
A diagnostic kit for the detection of ferric iron (PERLS,
BioOptica, Milan, Italy) was employed to stain hAFCs following
the manufacturer’s instructions. Images were captured by a CCD
camera connected to a Leica DMRS/HCS (Wetzlar, Germany)
microscope.
hAFCs were immunostained with a specific primary antibody
against the carboxydextran (1:1,000, StemCell Technologies,
Vancouver, Canada) followed by a goat-anti mouse secondary
antibody (1:1,000, Alexa-546, Molecular Probes, Invitrogen) in
PBS with Normal Goat Serum (NGS). The fluorescence was
visualized by Olympus Fluoview microscope BX61 (Tokyo, Japan)
with confocal system FV500 equipped by specific lasers
(lexc=405 nm and lexc=546 nm) to visualize Hoechst 33258
and Alexa-546 respectively. To avoid possible false positive results,
immunofluorescence experiments were also done using the
primary or the secondary antibodies alone without observing
any staining.
Transmission Electron Microscopy (TEM)
hAFCs were pre-fixed with 4% paraformaldehyde and 1%
glutaraldehyde in Hepes 0.2 M (pH 7.4) and fixed at 4uCi n1 %
glutaraldehyde in Hepes 0.2 M, pH 7.4 until use.
Thirty minutes after incubation with 1% osmium, hAFCs were
incubated for 5 minutes at Room Temperature (RT) with a
saturated solution of thiocarbohydrazide followed by 1.5%
ferrocyanide and 1% osmium for 30 minutes. hAFCs were then
counterstained with 0.5% uranyl acetate overnight at 4uC,
dehydrated in graded series of ethanol, embedded in Epoxy
medium (Epon 812 Fluka, Sigma Aldrich) and polymerized at
60uC for 72 hours. From each sample, ultrathin (55–60 nm thick)
sections were cut with a Leica EM UC6 ultramicrotome and
examined with an EFTEM equipped with a YAG scintillator slow
scan CCD camera (Zeiss).
FACS
Both control and double-labeled hAFCs were analyzed by
cytofluorymetric analysis. Cells were harvested with trypsin, and
incubated for 20 minutes at RT with fluorescein-conjugated
(FITC)-anti CD105, phycoerythrin-conjugated (PE)-anti CD90,
PE-anti CD73 and PE-anti CD146 (all from Becton Dickinson,
Franklin Lakes, NJ, USA). After 10 minutes of lysis (FACS Lysing
Solution, Becton Dickinson), the samples were centrifuged. The
pellets, suspended in 400 ml of PBS, were acquired by a flow
cytometer (FACSCanto II Becton Dickinson) and analyzed using
Diva software. FITC Annexin V in conjunction with propidium
iodide (PI, both from Sigma Aldrich) were used following the
manufacturer’s instructions. For cell cycle analysis, hAFCs were
fixed in 1 ml of 70% ethanol for at least 2 hours, treated with
0.5 mg/ml of RNaseA (Sigma Aldrich) in PBS with 0.1% saponin
for 1 hour at 37uC, stained with 20 mg/ml of PI, and analyzed for
DNA content. For each sample, at least 5610
4 events were
collected.
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hAFCs were double-labeled with the SPIOn and Hoechst
33258, as previously described, and both viability and proliferation
were assessed at different time points (T0, T3, T7 and T10; T are
expressed as days in vitro).
Viability of cells was evaluated by a 3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) assay (CellTilter 96H AQueous Assay, Promega, Madison,
WI, USA). Labeled cells were plated in 96-well plates at a density
of 50,000 cells/well and maintained at 37uC for 1 hour. MTS
solution (20 ml/well) was added to cells and incubated for 1 hour
at 37uC. The supernatant was then collected, centrifuged at
2,0006g for 5 minutes and read at 490 nm with a microplate
reader (Elx800, Bio-Tek Instruments Inc., Winooski, VT, USA).
Maintenance of cell proliferation was tested by plating 750,000
cells/well in quadruplicate in 12-well plates. At each defined time
point (T0, T3, T7 and T10) hAFCs were counted and re-plated at
the initial concentration to verify any possible difference in
proliferative rates between controls and double-labeled hAFCs.
For counting, cells were collected, centrifuged at 1,0006g for
10 minutes and suspended in 500 ml of fresh medium. Thereafter,
vital cells were counted using the Trypan blue (Sigma Aldrich)
exclusion method.
Animals
Wobbler mice and healthy littermates were bred at Charles
River (Calco, Lecco, Italy). Since heterozygous mice do not show
any phenotypic difference compared to homozygous healthy
littermates, heterozygous founders were determined by genotyping
[19].
Table 1. Experimental groups for in vivo analyses.
Group Days
21 0 121 4 2 8 5 6
1 (H; n=4) M L hAFCs M/S
2 (W; n=4) M L hAFCs M/S
3 (H; n=4) M L hAFCs M M/S
4 (W; n=4) M L hAFCs M M/S
5 (H; n=6) M L hAFCs M M/S
6 (W; n=6) M L hAFCs M M/S
7 (H; n=4) M L hAFCs M M M/S
8 (W; n=4) M L hAFCs M M M/S
9 (H; n=2) M U hAFCs M M/S
10 (W; n=2) M U hAFCs M M/S
11 (H; n=2) M PBS M M/S
12 (W; n=2) M PBS M M/S
13 (W; n=2) M Free SPIOn M M/S
14 (H; n=2) M PBS M M/S
Days are referred as days after transplantation (corresponding to Day 0).
H: healthy mice; W: wobbler mice, M: MRI; L hAFCs: SPIOn/Hoechst 33258
labeled cells; U hAFCs: unlabeled cells; S: sacrifice.
doi:10.1371/journal.pone.0032326.t001
Figure 1. In vitro measurements of SPIOn. (A) Size distribution and (B) zeta-potential measured in distilled water, saline solution and Amniomax
II by DLLS. (C–D) Representative images of SPIOn spotted on the mica and visualized by AFM. (C) SPIOn are mainly monodispersed although a small
number of chain-like clusters (red arrow) were found. (D) AFM picture shows the spheroid shape of SPIOn. (E) EFTEM images of SPIOn. Single particles
were detectable, despite aggregation caused by magnetic forces, confirming data obtained by AFM. Red spots indicate the ESI analysis for iron. Scale
bars: C=1 mm; D–E=40 mm.
doi:10.1371/journal.pone.0032326.g001
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conformity with the institutional guidelines that are in compliance
with international laws and policies (EEC Council Directive 86/
609, OJ L 358, 1 Dec.12, 1987; NIH Guide for the Care and use
of Laboratory Animals, U.S. National Research Council, 1996).
This specific protocol for the use of laboratory animals was
approved by the Italian Ministry of Health and by an internal
ethical committee (as stated on the Ethical Committee Approval
document (ID.#A5023-01) by the NIH-Office for Protection from
Research Risks).
Four weeks old wobbler mice and age-matched healthy
littermates, were enrolled for this study. Wobbler mice were easily
identified by phenotype features, such as the drastic reduction of
growth (in length and body weight) and the appearance of
sustained tremors [9].
Wobbler and healthy mice received, under anesthesia, 100,000
double-labeled hAFCs resuspended in 5 ml sterile PBS into the
lateral cerebral ventricles (2.5 ml/ventricle, intracerebroventicular
administration, ICV) as previously described [6]. All animals daily
received cyclosporin A (Sigma-Aldrich) (0.1 mg/ml in drinking
water) to avoid rejection of human cells.
To verify if the administration of hACFs alone may modify the
hyper-intense signal and lead to important alteration in brain
ventricles (e.g. hydrocephalus), four weeks old wobbler mice and
healthy littermates also received, under anesthesia, the same
number/volume of iron-free hACFs or PBS alone. MRI analyses
were carried out 1, 7 and 28 days after graft.
Moreover, to evaluate the clearance of free SPIOn in the
ventricular system, four weeks old wobbler mice and healthy
littermates received, under anesthesia, 35 mg/ml of SPIOn diluted
in 5 ml of sterile PBS by ICV injection. MRI analyses were carried
out before SPIOn administration, 1, 24 and 48 hours after ICV
injection, as described in Magnetic Resonance Imaging section.
The whole experimental schedule is reported in Table 1.
Figure 2. Detection of SPIOn internalization in hAFCs. (A) Representative picture of Prussian blue staining. Internalization process of SPIOn in
hAFCs involved the whole cell population regardless the different morphologies. (B) Higher magnification figure of Prussian blue staining. (C)
Representative figure of Hoechst 33258 (blue) and anti-carboxydextran staining (green). (D) Higher magnification picture of carboxydextran and
Hoechst 33258 internalization. (E) Aggregates of SPIOn not enclosed by a membrane in the cytoplasm of hAFCs (red arrows). (F) TEM analysis in iron-
free hAFCs (F). Scale bars: A–C=100 mm; B–D=20 mm. E=1 mm.
doi:10.1371/journal.pone.0032326.g002
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MRI experiments were performed on a 7 T/30 cm horizontal
bore magnet (Bruker-Biospin, Ettlingen, Germany) equipped with
a 12-cm gradient set capable of supplying up to 400 mT/m. T2w
images were obtained using a spin-echo MRI sequence (TR/
TE=4000/36 ms, 78 mm
2 in-plane resolution, FOV 262c m
3,
matrix size=2566256, slice thickness=1 mm).
During MRI, the animals were anesthetized by breathing a
mixture of 1% isoflurane, 30% O2, 70% NO2. The animal
temperature was kept at 36 +/21uC using a warmed cradle.
Regions of interest (ROIs) were manually defined, using a
mouse brain atlas as a reference [20], with ImageJ software
(http://rsbweb.nih.gov/ij/). All the hypo-intense zones were
selected and compared to the total brain parenchyma volume.
The ratio between the two areas at different time points in healthy
and wobbler mice was then compared.
Histology
To ensure optimal quality for cryostat sections, animals were
transcardially perfused as previously described [21].
Figure 3. FACS analysis of hAFCs. Evaluation of cell cycle revealed that there were no differences between unlabeled (A) and SPIOn/Hoechst
33258 positive hAFCs (B). In all, 50,000 events per histogram were analyzed (horizontal axis: linear fluorescence intensity; vertical axis: relative cell
number). Additional data are reported in Table 2.
doi:10.1371/journal.pone.0032326.g003
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primary antibody directed against carboxydextran (1:200, Stem-
Cell Technologies) followed by a goat-anti mouse secondary
antibody (1:1,000, Alexa-488, Molecular Probes, Invitrogen) in
PBS with NGS. Similarly, a primary monoclonal antibody
directed against Human Leucocyte Antigens (HLA)-Class
I(1:500, Immunological Science, Rome, Italy), was utilized to
reveal the presence of human cells in the brain ventricles of both
healthy and wobbler mice. A secondary anti mouse antibody
(1:1,000, Alexa-546, Molecular Probes, Invitrogen) was utilized to
reveal the signal.
Sections were analyzed with a BX81 microscope equipped with
a F-view II CCD camera (Olympus). Co-localization between the
signals for Hoechst 33258 and Alexa-546 was analyzed by an
unmixing fluorescence module to exclude the possible crosstalk
between channels.
Statistics
All values are expressed as mean 6 SD. Comparison between
groups was made by ANOVA or the Welch’s t-test, as specified in
the respective figure/table legends, using a dedicated statistical
software (GraphPadPrism Inc. La Jolla, CA, USA). The minimum
level of statistical significance was set at p,0.05.
Results
In vitro characterization
The weekly DLLS measurements (Figure 1, A and B) showed that
neither the prolonged incubation (56 days) nor the different type of
medium modified the size, the polidispersity index and the zeta
potential of SPIOn. The visualization by AFM confirmed that SPIOn
are monodispersed and homogeneous for size/shape (Figure 1, C and
D). The presence of iron domains in SPIOn is shown in Figure 1, E
(red spots enclosed in gray spheres). It is of interest to notice that red
spots are not homogeneously distributed in SPIOn but seem to align
by forming a magnetic field. All these experiments were important to
verify the stability of SPIOn in biological samples.
Tracer internalization
Prussian blue staining revealed a high efficiency of SPIOn
internalization into hAFCs 72 hours after incubation (Figure 2, A).
High magnification picture showed a selective staining in the
cytoplasm (Figure 2, B). Such feature was confirmed by the co-
localization experiments between carboxydextran immunostaining
(green) and the nuclear staining by Hoechst 33258 (blue) (Figure 2,
C and D). Unlabeled hAFCs did not show any positive staining for
either tracer (not shown).
TEM showed small clusters of SPIOn not surrounded by a
membrane (Figure 2, E, red arrows) in the intracellular space close
to the perinuclear area, but not inside the nuclei. The presence of
SPIOn did not modify the morphology of either organelles
(endoplasmic reticulum, Golgi apparatus, mitochondria, endo-
somes) and cellular membranes of hAFCs, as confirmed by the
comparison with the ultra structure of iron-free cells (Figure 2, F).
Viability and proliferation
SPIOn/Hoechst 33258 labeling in hAFCs did not lead to
significant changes either in the cell cycle or in the percentage of
cell surface markers. Representative results are shown in Figure 3
and summarized in Table 2. No statistically significant difference
between groups was observed. Moreover, SPIOn internalization
did not increase the percentage of Annexin V/PI positive cells
(Figure 4, A). The simultaneous internalization of SPIOn and
nuclear labeling did not alter physiological parameters of hAFCs:
at different time (T0, T3, T7 and T10) there was no significant
difference in proliferative rate between controls and double-
labeled hAFCs (Figure 4, B). Furthermore, MTS assay revealed
that metabolism of double-labeled hAFCs was comparable to
control, indicating that SPIOn is not toxic for cells (Figure 4, C).
In vivo visualization of hAFCs and free SPIOn in cerebral
ventricles of transplanted mice
T2 weighed MRI coronal brain slices showed a diffused light
gray shade representing the brain parenchyma whereas a brighter
hyper-intense signal was associated with brain ventricles (Figure 5,
A). A hyper-intense signal was observed in the ventricular system
of wobbler mice receiving PBS alone (Figure 5, A, see arrows) one
day after ICV, while a hypo-intense signal was observed in animals
receiving hACFs loaded with SPIOn (Figure 5, B, see arrows).
Conversely, the hyper-intensity was preserved after unlabeled
hACF graft (Figure 5, C, see arrows).
The MRI signal still remained comparable between 1 and 28
days after administration of PBS (Figure 5, D), SPIOn-labeled
hACFs (Figure 5, E) or iron-free hAFCs (Figure 5, F),
Interestingly, the comparison between animals treated with PBS
(Figure 5, A and D), labeled (Figure 5, B and E) and iron-free
hAFCs (Figure 5, C and F) did not show any differences in the
morphology of the ventricular compartments for at least 28 days
after ICV transplantation, irrespectively of the pathology.
Before SPIOn injection (untreated animals) a strong hyper-
intense signal was clearly visible in the ventricular systems
(Figure 5, G, see arrows) similarly to animals treated with PBS
alone (Figure 5, A). Traceability, distribution and half-life of
SPIOn in the lateral ventricles of a four weeks old wobbler mouse
at different time points is shown in Figure 5 H–J.As expected,
1 hour after ICV administration of SPIOn, the hypo-intense
signal rapid spread in the whole ventricular system, as revealed
by dark regions in different compartments (Figure 5, H,s e e
arrows). In contrast to the persistent signal retrieved after SPIOn
labeled-hAFC graft (see Figure 5, E, see arrows), the hypo-intense
signal rapidly decayed in animals receiving SPIOn alone
(Figure 5, I, see arrows). Twenty-four hours after ICV, hypo-
intense areas associated with lateral ventricles, cerebellum and
Table 2. Cytofluorimetric results comparing marker
expression, apoptotic/dead cells and number of hAFCs in the
different cell cycle phases between controls (unlabeled) and
SPIOn/Hoechst 33258 labeled cells.
Unlabeled hAFCs Labeled hAFCs
PHENOTYPE
CD105+ 14.03610.7 13.4369.9
CD90+ 50.23615.6 47.2612.6
CD73+ 8664.9 79.77611.5
CD 146 61.16630.3 45.87629.5
APOPTOSIS AND DEATH
4.263.3 563.1
CELL CYCLE
G2 55655 2 60.5
S 1.960.9 1.760.9
G0G1 761.6 5.560.05
Data are expressed as the percentage of three independent experiments 6 SD.
Statistical analysis: Welch’s t-test.
doi:10.1371/journal.pone.0032326.t002
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to Figure 5, H. Forty-eight hours after SPIOn administration,
MRI images showed a very mild area of hypo-intense signal in
correspondence to the site of administration (Figure 5, J,s e e
arrow in L.V.) whereas in the other regions the signal was similar
to that observed before their injection (Figure 5, G). Our study
did not reveal any different SPIOn behavior between healthy and
wobbler mice.
In vivo/ex vivo hAFC tracking
MRI, performed one day before hAFC transplantation, showed
a marked hypo-intense signal both in healthy (Figure 6, A, see
arrows) and wobbler mice brains (Figure 6, B, see arrows).
One day after SPIOn loaded-hAFC administration, the signal in
the brain ventricles became darker and hypo-intense in both
healthy (Figure 6, C, upper panels, see arrows) and wobbler mice
(Figure 6, D, upper panels, see arrows). This effect rapidly spread
along the whole ventricular system in both experimental groups
and reached the fourth ventricle around the cervical spinal cord.
On the contrary, MRI from animals receiving iron-free hAFCs did
not reveal any modification on the hyper-intensity of signal
associated with the cerebrospinal fluid (CSF). Fourteen days after
hAFC graft, in both healthy (Figure 5, C, middle panels) and
wobbler mice (Figure 5, D, middle panels), the pattern of hypo-
intense signal was not markedly reduced, did not modify its
distribution in ventricles and did not seem to spread to the brain
parenchyma. The hypo-intense signal in the brain ventricles of
both experimental groups decayed 56 days after transplantation
(Figure 6, C and D, lower panels) while remaining detectable in the
whole ventricular system. Serial MRI slices corresponding to the
ventricular system (Figure 7, A) were used to perform a
longitudinal measurement of hAFC distribution in both wobbler
and healthy mice (n=4 for each group) by calculating the ratio
between the volume of hypo-intense signal (Figure 7, B, light blue
Figure 4. Evaluation of vital parameters in labeled hAFCs. (A) Representative figure of apoptosis measurement by Annexin V/PI staining and
FACS analysis. The lower left fractions of each panel indicate viable cells (Annexin negative-PI negative, Q3). Early (Annexin positive-PI negative, Q1)
and end stage (Annexin positive- PI positive, Q2) apoptotic cells are in the upper left and upper right fractions respectively. Dead cells (Annexin
negative-PI positive, Q4) are in the lower right fractions. No significant differences were found between the two experimental groups (see also
Table 2). (B) Proliferation of hAFCs. SPIOn and Hoechst 33258 internalization did not influence the proliferative capability of cells. T is expressed as
days in vitro. Data are mean 6 SD from 2 replicates of 3 different experiments. Statistical analysis: Two-Way ANOVA and Bonferroni post test for
multiple comparisons. (C) Metabolic activity assessment. MTS assay showed no differences between control and SPIOn/Hoechst 33258 labeled hAFCs,
at either T0 or 10 days after labeling. Data are expressed as mean 6 SD from 2 replicates of 3 different experiments. Statistical analysis: Two-Way
ANOVA and Bonferroni post test for multiple comparisons.
doi:10.1371/journal.pone.0032326.g004
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yellow area). A progressive decrease of hypo-intense volume
occurred in both experimental groups, but no relevant difference
was found by comparing the signal decay over time (Figure 7, C).
This evidence was also a confirmed by ex vivo studies (Figure 8,
A–D). The MRI coronal slice from a wobbler mouse, 28 days after
cell graft, showed a hypo-intense signal in the lateral and third
ventricles (Figure 8, A). The corresponding histological section (the
mouse was sacrificed few minutes after MRI) showed the presence
of Hoechst 33258 positive nuclei exclusively confined to the
ventricular system and overlapping with the MRI hypo-intense
signal (Figure 8, B). A similar pattern of hypo-intense MRI signal
(Figure 8, C) and Hoechst 33258 positive nuclei (Figure 8, D) was
found in the lateral ventricles close to the ventral hippocampus.
High magnification imaging of an adjacent brain section (Figure 8,
E) showed a cellular co-localization between the brown staining
associated with iron accumulation (cytoplasmic) and the Hoechst
33258 staining (nuclear) (Figure 8, F). The merge of the
carboxydextran immunoreactivity (green staining) and the
Hoechst 33258 in the following brain section, confirmed that iron
accumulation was actually associated with SPIOn (Figure 8, G).
Moreover, the co-localization experiment between Hoechst 33258
and HLA-I (Fig. 8 H), confirmed that almost all the Hoechst
33258-positive cells in the ventricular system also expressed the
human endogenous marker.All these data reveal the very high
correlation between the nuclear tracer Hoechst 33258 and: 1) the
hypo-intense signal from MRI; 2) the dark brown deposition
(typical of iron oxides); 3) the carboxidextran (coating agent of
SPIOn); 4) the human endogenous marker HLA-I. Altogether, our
experimental evidence strongly confirmed the reliability of
Hoechst 33258 labeling, thus enabling us to directly track hAFCs
by the evaluation of positive nuclei in the brain and spinal cord of
healthy and wobbler mice at different times after transplantation
(see Text S1 and Figure S1).
Figure 5. Representative longitudinal MRI of wobbler mouse brains 1 day after ICV administration of PBS (A), hAFCs labeled with
SPIOn (B) and iron-free hAFCs (C). Representative longitudinal MRI of the same mouse brain 28 days after ICV administration of PBS (D), hAFCs
labeled with SPIOn (E) and iron-free hAFCs (F). Arrows indicate the different compartments of brain ventricles: L.V.: lateral ventricle; CB: cerebellum;
S.C.: spinal cord. Representative longitudinal MRI of wobbler mouse brains before (G), 1 (H), 24 (I) and 48 hours (J) after SPIOn administration. For
each panel, the sagittal slice is representative of the region comprising lateral ventricles (L.V.), cerebellum (CB) and fourth ventricle at the spinal cord
level (S.C.), as indicated by arrows.
doi:10.1371/journal.pone.0032326.g005
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study, suggesting that the ICV transplantation of SPIOn/Hoechst
33258 labeled hAFCs did not lead to acute toxicity in either
wobbler or healthy mice. In addition, the lack of apparent
alteration to ventricular morphology (see Figure 5, A–F), and the
very weak expression of markers for leukocyte infiltration (see Text
S1 and Figure S2), further supports the hypothesis of a safe and
reliable approach by these two fluo-paramagnetic tracers in hAFC
ICV transplantation.
Discussion
In this study, we described for the first time the paramagnetic
labeling of hAFCs and their subsequent long-term tracking in a
chronic neuro-degenerative/inflammatory environment, such as
wobbler mice brains. We demonstrated that hAFC survival was not
altered by the presence of double tracers, permitting substantial
correlations between in vivo and ex vivo data at different times. Finally,
the overall result emerging from our experiments suggests that this is
a reliable strategy able to combine a high and satisfactory level of
biocompatibility with an efficient and long lasting cell labeling.
Initially, we focused our attention on the chemico-physical
properties of SPIOn when incubated in different media, to exclude
possible interactions with biological proteins and to reproduce the
conditions that SPIOn encountered during the process of cell
internalization. DLLS, AFM and ESI analyses did not suggest any
important alteration of SPIOn stability for at least56 days. This result
is in accordance with previous studies performed by DLLS [22].
Once we had ascertained SPIOn stability over time, we verified
the dynamics of their uptake and the consequent sub-cellular
distribution.
Figure 6. MRI of labeled hAFCs. Representative pictures of MRI of healthy (A) and wobbler (B) mice one day before hAFC
transplantation. Axial MRI analysis of the same healthy (C) and wobbler mice (D) at 1, 14 and 56 days after graft. For each panel, the coronal slices
are indicative of different regions of the ventricular system including the site close to cell administration (L.V.), the region corresponding to the
ventral hippocampus (HP), the region between the brainstem and the cerebellum (CB) and the cervical spinal cord region (S.C.).
doi:10.1371/journal.pone.0032326.g006
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35 mg/ml concentration of SPIOn which allows 100% labeling
efficiency, even in rapidly proliferating adhesive cells, such as
hAFCs, avoiding the toxic effects related to higher SPIOn content.
Prussian blue and carboxydextran staining confirmed the ability of
SPIOn to be internalized into cells and to selectively spread in the
cytoplasm [13]. The visualization by TEM of cytoplasmic small
iron aggregates not surrounded by membranes, suggested that
SPIOn internalization into hAFCs is based on a non-endocytic
mechanism or an endosomolytic uptake [24] and did not alter sub-
cellular morphology. Moreover, the lack of significant differences
in viability and functionality between double-labeled and control
cells further confirmed that neither cell phenotype, nor replication
were influenced by the presence of SPIOn [25]. In view of
potential clinical applications, it is also noteworthy that iron
labeling does not alter cell division, providing some reassurance
about their possible tumorigenic potential [26].
In addition, simultaneous internalization of SPIOn and Hoechst
33258 did not affect proliferation and metabolic activity in hAFCs.
In agreement with published data [23,27], these parameters
appeared similar to control cells at the different time-points
considered in the study. The slight increase in metabolic activity at
T0 and T7 observed in cells loaded with SPIOn could be related
to the higher iron concentration available for biological processes
inside cells, as suggested by Arbab and colleagues [27]. The lack of
SPIOn toxicity upon internalization was further confirmed by
Annexin V/PI staining which excluded different apoptotic/death
rates in cells, concordantly with previous publications [26].
We did not observe adverse side effects after double-labeling
with regard to both animal and cell distribution, further
underlining the safety of the procedure. Our main findings were
that: 1) the rate of mortality, monitored over the 56 days after
transplantation, was indeed very low and did not differ from the
animals receiving PBS/unlabeled hAFCs, and 2) macroscopic
features of inflammatory response and rough modification of the
ventricular system were not observed in either wobbler or healthy
mice throughout the duration of our study. These results seem to
confirm the reliability of labeled hAFCs for future investigation of
therapeutic efficacy in models of neurological disorders.
In the last decade, a large number of studies have been
published regarding the in vivo tracking of different SC types
loaded with SPIOn, administered by several routes, in different
pathological conditions [26]. The MRI analysis we performed in
healthy and wobbler mice receiving hAFCs labeled with multi-
Figure 8. Ex vivo analyses. (A) MRI pictures showing axial slices corresponding to the lateral ventricle close to the site of administration. (B)
Histological section observed by UV shows the presence of Hoechst 33258 positive nuclei in the ventricular area. (C) MRI axial slice close to the
ventral hippocampus. (D) Fluorescent microscopy of histological section revealed a co-localization between Hoechst 33258 and MRI signal. (E) Iron
accumulation in the brain section adjacent to that shown in figure D. (F) High magnification picture showing the merge between iron accumulation
and Hoechst 33258 positive nuclei. (G) Merge between the carboxydextran immunoreactivity (green) and Hoechst 33258 positive nuclei (blue). (H)
Merge between the HLA-I (red) and Hoechst 33258 positive nuclei (blue). Scale bars: B–D–E=600 mm; F–G=45 mm; H=30 mm.
doi:10.1371/journal.pone.0032326.g008
Figure 7. Relative quantification of MRI signal. (A) Acquisition scheme of serial slices selected for the quantification of volumes. (B)
Representative slice showing the ROI manually defined for the volume quantification. Light blue areas show the hypo-intense signal, while yellow
area show the brain parenchyma. (C) Quantification of the percentage of hypo-intense volume in the brain. No significant difference was found
between wobbler mice and healthy controls 1, 14 and 56 days after hAFC transplantation. Data are expressed as mean 6 SD (n=4) for each group.
Statistical analysis: Two-Way ANOVA and Bonferroni post test for multiple comparisons.
doi:10.1371/journal.pone.0032326.g007
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PLoS ONE | www.plosone.org 10 February 2012 | Volume 7 | Issue 2 | e32326modal exogenous tracers, revealed that the signal rapidly spread
up in/to the spinal cord, remained confined to the ventricles, and
decayed over time, but was still detectable up to the endpoint of
our study.
As previously documented [28], a combined in vivo and ex vivo
study was carried out in mice at different times after hAFC graft to
establish whether the hypo-intense signal observed in brain
ventricles was actually associated with the fluorescent tracer.
The visualization of a large number of Hoechst 33258 positive
nuclei in relation to the MRI signal confirmed the presence of
transplanted cells. Although some leakage of the nuclear dye from
grafted cells to host tissue remains possible [29], the co-localization
of Hoechst 33258 with either the carboxydextran or anti HLA
supports our findings.
In the literature, the issue of SPIOn leakage has already been
investigated: Flexman et al., [30] demonstrated that the MRI
signal was still detectable one week after intraparenchymal
injection of free tracer. Conversely, we demonstrated that within
the first 24 hours, the pattern of hypo-intense signal for free
SPIOn (35 mg/ml), injected in mice by ICV, was comparable to
the distribution of transplanted iron-positive cells. However, in the
following 48 hours, the signal rapidly faded and completely
disappeared. This difference could be due to the rapid flow of
CSF across the ventricular system that allows a fast clearance of
free tracer. Altogether the data presented here support the
hypothesis of SPIOn persistence inside viable cells for the whole
longitudinal study in our experimental conditions
It has already been demonstrated that the relative quantification
of SPIOn-labeled cells by MRI is feasible and useful for studying
cell migration through specific tissues [28]. However the large
majority of measures were carried out using labeled cells grafted in
parenchymal tissue after acute damage [31,32] while our
comparison was conducted for the first time in a chronic model
of disease with labeled hAFCs directly injected in the ventricular
system. Concordantly, our quantification did not reveal any
important difference in the anatomical/temporal cell pattern, in
either healthy or wobbler mice.
It is important to underline that the therapeutic effect in
different chronic (neuro)degenerative disorders is now predomi-
nately associated with SC permanence and the release of several
factors by transplanted cells, even far from the site of injury [3,33].
As a matter of fact we have already demonstrated that ICV
injection of SCs in two different ALS animal models (SOD1G93A
and wobbler mice) resulted in significant therapeutic improve-
ments although no cell localization in the pathological tissue was
observed [6]. Moreover, intrathecal and intravenous SC admin-
istration have already been tested in a preliminary clinical trial
aimed at demonstrating the safety and immunological effects of
mesenchymal SC transplantation in patients with multiple sclerosis
and ALS [34]. Direct (multiple) injection in the brain ventricles is
less invasive than intraspinal administration and is capable of
extensively delivering cells via the CSF [35] with therapeutic
improvements devoid of side-effects [36]. On the other hand, no
evident clinical benefits have been detected so far in ALS patients
after intraspinal delivery of autologous mesenchymal SCs [37].
The data presented here demonstrate that hAFCs rapidly diffuse
throughout the forth ventricle at the level of the spinal cord,
however, they did not migrate into the parenchyma. Survival and
long-term spreading of hAFCs appeared particularly intriguing
since cell diffusion from the brain towards damaged areas become
exploitable to avoid invasive intraspinal implantation of SCs in
patients.
Altogether our data describe for the first time the potential of
ICV transplantation and long-term SC imaging in a mouse model
of ALS, characterized by an ongoing degenerative environment. A
final novel point which emerged from this work is the concomitant
employment of a nuclear-fluorescent marker with a well-
characterized super paramagnetic cytoplasmic tracer in SCs
obtained from fetal tissues.
Additional preclinical trials, aimed at coupling the tracking of
SPIOn-labeled hAFCs to their possible therapeutic effect are
however, required to elucidate their potential in clinical therapy
for motor neuron disorders.
Supporting Information
Figure S1 Tracking of Hoechst 33258 positive hAFCs in
transplanted brain of wobbler mouse. (A–F) Distribution of
Hoechst 33258 labeled cells in the lateral ventricles close to the site
of hAFC injection (A), the choroid plexus (B), the 3
rd ventricle (C),
the lateral ventricles close to the ventral hippocampus (D), the
brainstem (E) and the spinal cord (F) 1 day after hAFC
transplantation. Scale bar: A, B, F=200 mm; C, D=150 mm;
E=120 mm. (G–J) Localization of Hoechst 33258 positive nuclei
14 days after hAFC graft. Scale bar: G, H, I, K=150 mm;
J=120 mm. (L) High magnification picture shows a cluster of
Hoechst 33258 positive nuclei attached to the meningeal layer at
the cervical spinal cord level. Scale bar=40 mm. (M–Q)
Localization of Hoechst 33258 positive hAFCs 28 days after
transplantation. Scale bar: M, P, Q=200 mm; N, O=150 mm.
(R–U) Distribution of Hoechst 33258 positive nuclei in lateral
ventricles (R, S), third ventricle (T) and brainstem (U) 56 days post
grafting. Scale bar=150 mm. (V) High magnification picture
showing a group of Hoechst 33258 positive nuclei in the ventral
region of white matter at the cervical spinal cord level. Scale
bar=40 mm. L.V.: lateral ventricle; C.P.: Choroid Plexus; 3V: 3
rd
ventricle); HP: Hippocampus; CB: cerebellum; AQ: aqueduct; BS:
brainstem; S.C.: spinal cord.
(TIF)
Figure S2 Analysis of leukocyte infiltration. (A–C) Rep-
resentative pictures showing the immunoreactivity for CD3 (A),
CD4 (B) and CD8 (C), in lateral ventricles of wobbler mouse brain
28 days after PBS administration. (D–F) Representative pictures
showing the immunoreactivity for CD3 (D), CD4 (E) and CD8 (F),
in lateral ventricles of wobbler mouse brain 28 days after
administration of SPIOn labeled hAFCs. (G–I) Representative
pictures showing the immunoreactivity for CD3 (G), CD4 (H) and
CD8 (I), in spleen sections 28 days after PBS administration in
brain lateral ventricles. Scale bar: (A–F)=40 mm; (G–I)=30 mm.
(TIF)
Text S1
(DOC)
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